There was a significant multiplicative interaction between the OBFC1 rs11191865 and TP53BP1 rs560191 in relation to lung cancer risk (OR for interaction = 2.44 (1.67/0.50*1.37), 95% CI = 1.02–5.87). Here, TP53BP1 is linked to lung carcinoma.